Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prezista Switch in HIV Patients Intolerant to Current Therapy
NCT00765154Phase 4Terminated
- Sponsor
- St Stephen's AIDS Trust
- Start
- Oct 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Oct 2008; status: terminated.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00765154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765154.